Related Experiment Videos
[Partial nephrectomy in renal cell carcinoma]
M A López-Costea1, C González-Satué, E Franco Miranda
1Servicio de Urología, Ciutat Sanitaria i Universitaria de Bellvitge (CSUB), Barcelona.
Actas Urologicas Espanolas
|September 6, 2001
Summary
Nephron Sparing Surgery (NSS) is a safe and effective treatment for renal cell carcinoma (RCC), particularly for small tumors. This study shows high survival rates and low morbidity with NSS, making it a valuable option for kidney cancer patients.
Area of Science:
- Urology
- Oncology
- Surgical Oncology
Context:
- Renal Cell Carcinoma (RCC) is a significant malignancy, with increasing incidental diagnoses of small renal tumors.
- The management of small renal masses often involves a balance between oncological control and preservation of renal function.
- Nephron Sparing Surgery (NSS) has emerged as a key surgical approach for selected renal tumors.
Purpose:
- To evaluate the outcomes of Nephron Sparing Surgery (NSS) for renal masses over a decade.
- To compare outcomes between elective and obligatory NSS.
- To assess the morbidity, mortality, and survival rates associated with NSS.
Summary:
- A retrospective analysis included 65 NSS procedures for renal tumors between 1990 and 2000.
- The study differentiated between elective (tumors <4cm, normal contralateral kidney) and obligatory NSS.
- Results demonstrated a cancer-specific survival of 98.4% and global survival of 90.3% at 36 months, with a morbidity rate of 10.8% and mortality of 1.5%.
Impact:
- NSS is a viable and effective treatment for renal cell carcinoma, especially for tumors under 4 cm.
- The technique is also beneficial for patients with a solitary kidney, preserving renal function.
- These findings support the continued application of NSS in the management of renal tumors.